Forest has well-established franchises in therapeutic areas of the central nervous, cardiovascular and respiratory systems, and we are always exploring new product opportunities that address a range of health conditions. Our principal brands include Lexapro®(escitalopram oxalate), Namenda®(memantine HCl) and Benicar®(olmesartan medoxomil). Forest identifies, develops and delivers pharmaceutical products that make a difference in people's lives. Lexapro is one of the fastest-growing SSRI antidepressant in the United States. Benicar has become an important treatment option for hypertension. Namenda is the first approved therapy in the United States for those with moderate or severe Alzheimer's disease.